Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Budesonide for Allergic Rhinitis in Children
NCT02409563Phase 4Completed
- Sponsor
- CNR-Institute for Biomedical Research and Innovation
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of EPI-EE in allergic rhinitis (AR), sponsored by CNR-Institute for Biomedical Research and Innovation. Started Jan 2014; status: completed.
02
Drugs
EPI-EE
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02409563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409563.